Anil Kumar, Phd Email & Phone Number

Athens, Ga, Us

▪ Led the development, evaluation, and testing methodologies for 4 successful formulations. Engineered 2 formulations for cancer and 1 for microbial infections (bacteria and fungus) and neurodegeneration. ▪ Designed and executed experiments to optimize drug loading /encapsulation, release kinetics, and stability of nanoparticle-based delivery platforms and therapeutic assessments.▪ Hands-on experience in bioconjugate techniques (EDC/NHS, DCC, SH coupling) for the functionalization of DNA, protein, peptides, antibodies, PEG modifications, small molecule drugs, and molecular probes on the polymer & nanomaterials surface for biomedical application.▪ Provide technical guidance and hands on support for method development and characterization, planned and completed experiments, including procedures (SOPs), results, data analysis, and conclusions in appropriate formats (lab notebook, NIH progress report).▪ Experience in handling, usage, storage, and disposal of laboratory chemicals waste according to local regulatory guidelines (UGA) in compliance with Health & Safety and EPA (Environment Protection Agency).

Athens, Ga, Us

Toxicity screening of chemotherapeutics (3), anti-inflammatory (NSAIDs) or neuroprotective drugs (6), against cancer and neuron stem cells (ischemic stroke model for tissue regeneration). ▪ Led efforts in polymer synthesis and creating nanoformulation, optimization, characterization, quality control, and scale-up synthesis for commercialization and manufacturing processes.▪ Conducted preclinical in vivo studies to evaluate the therapeutic behavior of drugs and formulations in biological systems, including biodistribution (BD) and pharmacokinetics (PK). Proficiently processed and analysed various clinical samples, such as blood, plasma, serum, and urine, to gain insight into drug BD, metabolism, and elimination pathways.▪ Collaborated with cross-functional teams (researchers, and clinicians) to conduct preclinical in vivo studies, including biodistribution (BD) and pharmacokinetics (PK) study of nanoformulations in large animal model (canine and swine).▪ Assisted (formulation subject matter expert) in developing new assay design, optimization, validation, troubleshoot and analysed the complex data in support of drug discovery project. Conducted pilot experiments to demonstrate feasibility of new concepts, methodologies, andapproaches.▪ Ability to communicate, interact, and build positive relationships with others effectively, and the ability to convey information clearly and respectfully

Beijing, Cn

▪ Developed various techniques for the fabrication and external modification of gold superparamagnetic magnetic NPs with precise particle size for biomedical applications in neuron cells differentiation including cell labeling/imaging, drug delivery, gene therapy.▪ Work in the synthesis and development of magnetic hydroxyapatite nanobelt-stem cell hybrid spheroids nanoparticles for remotely patterning bone tissue. ▪ Established protocols for nano-scaffold biocompatibility assessment, including extractable and leachable testing, real-time degradation testing, and in vitro cytotoxicity evaluation.▪ Established a method for studying the interaction of NPs with neuron cells and electric potential for toxicity and safety evaluation.

Beijing, Cn

Doctor Of Philosophy (Phd), Nanoscience And Technology

M.Sc, Microbial Sciences

B.Sc., Biotechnology, Chemistry, Zoology